These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 29863274

  • 1. Therapeutic potential of benfotiamine and its molecular targets.
    Raj V, Ojha S, Howarth FC, Belur PD, Subramanya SB.
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3261-3273. PubMed ID: 29863274
    [Abstract] [Full Text] [Related]

  • 2. The multifaceted therapeutic potential of benfotiamine.
    Balakumar P, Rohilla A, Krishan P, Solairaj P, Thangathirupathi A.
    Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Benfotiamine accelerates the healing of ischaemic diabetic limbs in mice through protein kinase B/Akt-mediated potentiation of angiogenesis and inhibition of apoptosis.
    Gadau S, Emanueli C, Van Linthout S, Graiani G, Todaro M, Meloni M, Campesi I, Invernici G, Spillmann F, Ward K, Madeddu P.
    Diabetologia; 2006 Feb; 49(2):405-20. PubMed ID: 16416271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroprotective Effects of Thiamine and Precursors with Higher Bioavailability: Focus on Benfotiamine and Dibenzoylthiamine.
    Sambon M, Wins P, Bettendorff L.
    Int J Mol Sci; 2021 May 21; 22(11):. PubMed ID: 34063830
    [Abstract] [Full Text] [Related]

  • 7. Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway.
    Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P.
    Circ Heart Fail; 2010 Mar 21; 3(2):294-305. PubMed ID: 20107192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives.
    Volvert ML, Seyen S, Piette M, Evrard B, Gangolf M, Plumier JC, Bettendorff L.
    BMC Pharmacol; 2008 Jun 12; 8():10. PubMed ID: 18549472
    [Abstract] [Full Text] [Related]

  • 12. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications.
    Beltramo E, Berrone E, Tarallo S, Porta M.
    Acta Diabetol; 2008 Sep 12; 45(3):131-41. PubMed ID: 18581039
    [Abstract] [Full Text] [Related]

  • 13. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine.
    Babaei-Jadidi R, Karachalias N, Ahmed N, Battah S, Thornalley PJ.
    Diabetes; 2003 Aug 12; 52(8):2110-20. PubMed ID: 12882930
    [Abstract] [Full Text] [Related]

  • 14. Benfotiamine attenuates inflammatory response in LPS stimulated BV-2 microglia.
    Bozic I, Savic D, Laketa D, Bjelobaba I, Milenkovic I, Pekovic S, Nedeljkovic N, Lavrnja I.
    PLoS One; 2015 Aug 12; 10(2):e0118372. PubMed ID: 25695433
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats.
    Stracke H, Hammes HP, Werkmann D, Mavrakis K, Bitsch I, Netzel M, Geyer J, Köpcke W, Sauerland C, Bretzel RG, Federlin KF.
    Exp Clin Endocrinol Diabetes; 2001 Aug 12; 109(6):330-6. PubMed ID: 11571671
    [Abstract] [Full Text] [Related]

  • 16. Thiamine and benfotiamine protect neuroblastoma cells against paraquat and β-amyloid toxicity by a coenzyme-independent mechanism.
    Sambon M, Napp A, Demelenne A, Vignisse J, Wins P, Fillet M, Bettendorff L.
    Heliyon; 2019 May 12; 5(5):e01710. PubMed ID: 31193162
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics of the transdermal delivery of benfotiamine.
    Zhu Z, Varadi G, Carter SG.
    Acta Diabetol; 2016 Apr 12; 53(2):317-22. PubMed ID: 26141141
    [Abstract] [Full Text] [Related]

  • 18. [Prophylactic and therapeutic application of thiamine (vitamin B1)--a new point of view].
    Małecka SA, Poprawski K, Bilski B.
    Wiad Lek; 2006 Apr 12; 59(5-6):383-7. PubMed ID: 17017487
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.